Hypovitaminosis D and the endocrine phenotype of COVID-19
- 18 March 2021
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 72 (1) , 1-11
Abstract
Background Vitamin D and its deficiency have recently been suspected to be involved in increased susceptibility and negative outcomes of COVID-19. This assumption was based on the well known immunomodulatory actions of vitamin D and on the consistent finding of low levels of 25 hydroxyvitamin D (25OHD) in hospitalized patients with COVID-19. Moreover, several studies reported a correlation between 25OHD levels and different clinical outcomes of the disease. Aim Aim of the current review was to approach the topic of vitamin D and COVID-19 from a different perspective summarizing the data which led to the evidence of the existence of an endocrine phenotype of COVID-19. Conclusions This review analyzed in the light of the current knowledge the possibility that several endocrine manifestations of COVID-19 could be holistically interpreted in the context of an inadequate vitamin D status.Keywords
This publication has 133 references indexed in Scilit:
- Vitamin D and the critically ill patientCurrent Opinion in Clinical Nutrition and Metabolic Care, 2012
- The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implicationsInternational Journal of Obesity, 2011
- Vitamin D Deficiency Is Associated With Retinopathy in Children and Adolescents With Type 1 DiabetesDiabetes Care, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2011
- Vitamin D Deficiency in Older MenThe Journal of Clinical Endocrinology & Metabolism, 2009
- Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004Archives of internal medicine (1960), 2009
- Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levelsDiabetic Medicine, 2008
- Effect of four monthly oral vitamin D 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Aging decreases the capacity of human skin to produce vitamin D3.Journal of Clinical Investigation, 1985